Maestro Insights
Intelligent software unlocking actionable insights from surgical data
Software · Cloud SaaSCompany source
Company profile
About Moon Surgical
Moon Surgical is a surgical robotics company developing the Maestro Platform to create the operating room of the future—one that is sustainable, efficient, and digitalized. The company's flagship product, the Maestro System, is an AI-enhanced robotic surgical assistance platform that provides intelligent camera control and instrument support for laparoscopic procedures, making advanced robotic technology accessible to all operating rooms without requiring complete system replacement. The platform includes Maestro Insights, intelligent software that unlocks actionable insights from surgical data. Moon Surgical's technology is designed to empower surgeons with total control while digitalizing the operating room environment. The system integrates with preferred surgical instruments and offers an expanded range of possibilities for surgical teams. Founded with a vision to advance global healthcare for patients and innovate the art of surgery, Moon Surgical has achieved FDA clearance and CE Mark certification for its commercial system. The company has treated over 200 patients and expanded into gynecological surgery beyond its initial focus on laparoscopic cholecystectomies. Moon Surgical's approach emphasizes accessibility, ease of use, and integration into existing surgical workflows, positioning the Maestro Platform as a complementary solution rather than a replacement for current operating room setups.
Company description Moon Surgical official website
Mission. Create the OR of the future, one that is sustainable, efficient, and digitalized.
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Work at Moon Surgical?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- general high-volume soft tissue procedures
- gynecological surgery
- laparoscopic cholecystectomies
Who it serves
- Ambulatory Surgery Centers
- Health Systems
- Hospitals
Deployment & integration
Cloud Saas · Embedded · On Premise deployment with recorded integration context.
Geographic context
MarketsEurope · France · United States
Company sourceOfficial website
Company milestones
Platform expansion
FDA clearance for AI-enhanced ScoPilot (March 2025), Launch at Lee Health (July 2025), Global ASC debut at Surgeon's Point Surgery Center (January 2025), ISO 27001 and SOC 2 certifications (October 2024), 2nd FDA clearance for commercial system (June 2024), Expansion to gynecological surgery (April 2024), 200+ patients treated milestone (March 2024)
Partnerships
Recorded partners
- King's College London
- NVIDIA
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Maestro System
Robotic surgery assistance platform for laparoscopic procedures
Device · On PremiseCompany source
ScoPilot
Industry's first AI-enhanced intraoperative capability for surgical robotics
Software · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Author Correction: The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring.Nature medicine · Apr 1, 2024
The IDEAL framework for surgical robotics: development, comparative evaluation and long-term monitoring.Nature medicine · Jan 1, 2024
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Maestro System (REF100)K250984 · 510k · Jun 27, 2025
Maestro System (REF100)K242323 · 510k · Mar 14, 2025
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Accessibility
Making robotic technology accessible to all operating rooms
Simplicity and ease-of-use
Demonstrated at Franche-Comté Polyclinic
Surgical performance scaling
Core value proposition of platform
Lee Health
Launch and deployment of Maestro Platform for robotic-assisted surgery
Surgeon's Point Surgery Center
Global debut of Maestro System in an ASC (Ambulatory Surgery Center) setting
Multiple U.S. Healthcare Facilities
First clinical cases in the U.S. using Maestro System for laparoscopic procedures
Over 200 patients treated with Maestro System
Franche-Comté Polyclinic
Showcase of Maestro System's simplicity and ease-of-use in surgical procedures
Arnault Tzanck Institute
Inaugural robotics surgeries with Maestro Commercial System in Nice, France
First-in-Human Clinical Study Sites
First human surgery using surgical assistance robotics device for laparoscopic cholecystectomies
Successful completion of first-in-human clinical study
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Chris Toth
Independent Board Member
Mark Toland
Board Member
Anne Osdoit
Chief Executive Officer
Pierre Campredon
Co-Founder & Board Observer (formerly CEO)
Lisa Jacobs
Vice President of Commercial Strategy
Anne Renevot
CFO
Jeffery Alvarez
Board Director
06 · Company updates
Updates from Moon Surgical
Recent articles published on Moon Surgical's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.